Início › Câncer de Pulmão › Connecticut › New Haven
Ensaios clínicos de Câncer de Pulmão em New Haven, CT
22 estudos para Câncer de Pulmão estão buscando participantes em locais em New Haven e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecrutandoFase 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · a 3 mi de distância
- Yale-New Haven Hospital North Haven Medical Center, North Haven · a 7 mi de distância
- e mais 2
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 2
- Yale Cancer Center, New Haven
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecrutandoFase 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · a 3 mi de distância
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecrutandoFase 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · a 7 mi de distância
- Smilow Cancer Hospital-Derby Care Center, Derby · a 8 mi de distância
- e mais 1
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RecrutandoFase 3
- Yale University, Smillow Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RecrutandoFase 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- e mais 1
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RecrutandoFase 2
- Research Site, New Haven
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RecrutandoFase 1
- Yale Cancer Center, New Haven
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
RecrutandoFase 1/2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · a 7 mi de distância
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecrutandoFase 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecrutandoFase 3
- Yale University School of Medicine, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecrutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RecrutandoFase 1
- Yale Cancer Center, New Haven
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecrutandoFase 1
- Xencor Investigative Site, New Haven
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RecrutandoFase 1/2
- Yale University Cancer Center, New Haven
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · a 5 mi de distância
- Yale-New Haven Hospital North Haven Medical Center, North Haven · a 7 mi de distância
- e mais 2
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- Smilow Cancer Hospital (Yale University), New Haven
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · a 7 mi de distância
- Smilow Cancer Hospital-Derby Care Center, Derby · a 8 mi de distância
- e mais 1
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · a 7 mi de distância
- Smilow Cancer Hospital-Derby Care Center, Derby · a 8 mi de distância
- e mais 1
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
RecrutandoVoluntários saudáveis bem-vindos
- Yale New Haven Medical Center, New Haven
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
RecrutandoEstudo observacional
- Yale School of Medicine, New Haven
Ensaios de Câncer de Pulmão em outras cidades
- Houston, TX78 estudos
- Boston, MA62 estudos
- New York City, NY60 estudos
- Los Angeles, CA45 estudos
- Washington, DC41 estudos
- Arlington, VA41 estudos
- Chicago, IL41 estudos
- Nashville, TN40 estudos
- Baltimore, MD40 estudos
- St. Louis, MO39 estudos
- Columbus, OH37 estudos
- Philadelphia, PA36 estudos
Outros estudos em New Haven
- Câncer de Pulmão de Não Pequenas Células41 estudos
- Câncer de Mama37 estudos
- Câncer (todos os tipos)33 estudos
- Câncer Metastático23 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço22 estudos
- Câncer de Ovário21 estudos
- Câncer Colorretal20 estudos
- Câncer de Próstata20 estudos
- Sobredose de Opioides18 estudos
- Transtorno por Uso de Álcool (AUD)17 estudos
- Leucemia Mieloide Aguda17 estudos
- Câncer de Pâncreas16 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.